| Authors: |
Lambourne OA; Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, U.K., Bell S; Wellcome Centre for Mitochondrial Research, Newcastle University, Tyne NE2 4HH, U.K., Wilhelm LP; MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee DD1 4HN, U.K., Yarbrough EB; Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, The University of Alabama at Birmingham, Birmingham, Alabama 35294, United States., Holly GG; Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, The University of Alabama at Birmingham, Birmingham, Alabama 35294, United States., Russell OM; Wellcome Centre for Mitochondrial Research, Newcastle University, Tyne NE2 4HH, U.K., Alghamdi AM; Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, U.K., Fdel AM; Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, U.K., Varricchio C; Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, U.K., Lane EL; Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, U.K., Ganley IG; MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee DD1 4HN, U.K., Jones AT; Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, U.K., Goldberg MS; Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, The University of Alabama at Birmingham, Birmingham, Alabama 35294, United States., Mehellou Y; Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, U.K. |